Vext Science, Inc.
VEXTF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $12,670 | $13,407 | $11,561 | $10,194 |
| % Growth | -5.5% | 16% | 13.4% | – |
| Cost of Goods Sold | $8,701 | $8,535 | $9,283 | $8,058 |
| Gross Profit | $3,969 | $4,872 | $2,278 | $2,136 |
| % Margin | 31.3% | 36.3% | 19.7% | 20.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $3,043 | $2,889 | $2,259 | $2,836 |
| SG&A Expenses | $3,043 | $2,889 | $2,259 | $2,836 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $2,393 | $2,460 | $2,162 | $2,192 |
| Operating Expenses | $5,436 | $5,349 | $4,421 | $5,028 |
| Operating Income | -$1,467 | -$477 | -$2,142 | -$2,892 |
| % Margin | -11.6% | -3.6% | -18.5% | -28.4% |
| Other Income/Exp. Net | -$1,404 | $741 | -$1,415 | -$4,303 |
| Pre-Tax Income | -$2,871 | $264 | -$3,557 | -$7,195 |
| Tax Expense | -$243 | $1,742 | -$223 | $2,020 |
| Net Income | -$2,628 | -$1,478 | -$3,334 | -$9,215 |
| % Margin | -20.7% | -11% | -28.8% | -90.4% |
| EPS | -0.011 | -0.006 | -0.014 | -0.05 |
| % Growth | -75% | 55.6% | 72.8% | – |
| EPS Diluted | -0.011 | -0.006 | -0.014 | -0.05 |
| Weighted Avg Shares Out | 247,618 | 247,581 | 247,490 | 180,168 |
| Weighted Avg Shares Out Dil | 247,618 | 247,581 | 247,490 | 180,168 |
| Supplemental Information | – | – | – | – |
| Interest Income | $41 | $42 | $101 | $40 |
| Interest Expense | $734 | $931 | $821 | $1,317 |
| Depreciation & Amortization | $4,006 | $4,110 | $3,742 | $3,871 |
| EBITDA | $1,869 | $5,305 | $1,006 | -$2,008 |
| % Margin | 14.8% | 39.6% | 8.7% | -19.7% |